Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience, Inc. Invites You to Join Its Second Quarter 2001 Conference Call on the Web
Harvard Bioscience, Inc. Invites You to Join Its Second Quarter 2001 Conference Call on the Web HOLLISTON, Mass., July 25 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the second quarter of 2001 after the market closes on Tuesday, July 31, 2001. At 6:00 p.m.
View HTML
Toggle Summary Harvard Bioscience, Inc. Acquires UK Company
Harvard Bioscience, Inc. Acquires UK Company HOLLISTON, Mass., Jul 2, 2001 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition, by its UK subsidiary, of International Market Supply LTD ("IMS"), a UK company engaged in developing, manufacturing and marketing a
View HTML
Toggle Summary Harvard Bioscience, Inc. President to Speak at the Thomas Weisel Partners Growth Forum 2001 Conference
Harvard Bioscience, Inc. President to Speak at the Thomas Weisel Partners Growth Forum 2001 Conference HOLLISTON, Mass., June 20 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will participate in a panel and make a
View HTML
Toggle Summary Harvard Bioscience, Inc. Acquires Union Biometrica, Inc., Whose Instruments Accelerate Drug Discovery
Harvard Bioscience, Inc. Acquires Union Biometrica, Inc., Whose Instruments Accelerate Drug Discovery HOLLISTON and SOMERVILLE, Mass., May 31, 2001 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of Union Biometrica, Inc. (UBI).
View HTML
Toggle Summary Harvard Bioscience, Inc. Receives NSF Grant For New High Throughput Toxicity Screening Assays
Harvard Bioscience, Inc. Receives NSF Grant For New High Throughput Toxicity Screening Assays HOLLISTON, Mass., May 24 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it and the University of Wisconsin, Madison, had received a grant from the National Science Foundation
View HTML
Toggle Summary Wall Street Transcript
Wall Street Transcript ***** THE WALL STREET TRANSCRIPT ***** 100 Wall Street, New York, NY 10005 VOICE: (212) 952-7400 FAX: (212) 668-9842; (212) 668-9858 Copyright1999WAL STREET TRANSCRIPT L CORPORATION-AllRightsReserved Website: http://www.twst.com E-mail:transcript@twst.com David Green
View HTML
Toggle Summary Harvard Bioscience Announces Collaboration with NextGen
Harvard Bioscience Announces Collaboration with NextGen HOLLISTON, Mass., May 9 /PRNewswire/ -- Harvard Bioscience Inc. (Nasdaq: HBIO) and NextGen Sciences Ltd. (Huntingdon, Cambridgeshire, United Kingdom), today announced a collaborative research and development agreement.
View HTML
Toggle Summary Harvard Bioscience, Inc. President to Speak at Dain Rauscher Wessels Genomics & Life Sciences Conference
Harvard Bioscience, Inc. President to Speak at Dain Rauscher Wessels Genomics & Life Sciences Conference HOLLISTON, Mass., May 3 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will make a presentation at the Dain Rauscher
View HTML
Toggle Summary Harvard Bioscience, Inc. Acquires Warner Instruments
Harvard Bioscience, Inc. Acquires Warner Instruments HOLLISTON, Mass., May 1 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of Warner Instruments Corporation, a leader in innovative cell and tissue electro-physiology research products.
View HTML
Toggle Summary HBIO Reports 29% First Quarter Revenue Growth
HBIO Reports 29% First Quarter Revenue Growth HOLLISTON, Mass., April 25 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the first quarter of 2001. Financial highlights for the three months ended March 31, 2001 were as follows: Revenues for the first
View HTML